Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 9781-9790 of 12000

Page
per page
  1. Ellagic acid
    A2306 Ellagic acid
    Summary: Casein kinase 2 (CK2) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.78 mg/mL
  2. Pamidronate Disodium
    A2456 Pamidronate Disodium
    Summary: Bisphosphonate antiresorptive agent & bone resorption inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
  3. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
  4. KU-0063794
    A5078 KU-0063794
    Target: mTOR
    Summary: MTORC1 and mTORC2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
  5. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2 inhibitor,ATP-competitive
      insoluble in H2O; ≥18.5 mg/mL
  6. Canertinib (CI-1033)
    A1845 Canertinib (CI-1033)
    Summary: HER family tyrosine kinase inhibitor
  7. AM1241
    A5827 AM1241
     2 Citation
    Summary: Cannabinoid CB2 receptor agonist,potent and selective
      ≥50.3 mg/mL
  8. PH-797804
    A8308 PH-797804
     1 Citation
    Summary: P38 MAP kinase inhibitor, potent and selective
      ≥23.85 mg/mL
  9. Go 6976
    A8341 Go 6976
    Target: PKC
    Summary: PKCα/PKCβ1 inhibitor
      ≥15.77 mg/mL
  10. Gabapentin
    A8436 Gabapentin
    Summary: GABA enhancer

Items 9781-9790 of 12000

Page
per page